Newsroom | 41787 results

LONDEN--(BUSINESS WIRE)--Aqemia, een TechBio pioniersbedrijf dat generatieve AI en op kwantum geïnspireerde fysica combineert om geneesmiddelen uit te vinden, maakt bekend dat Maximilien Levesque, CEO en medeoprichter, en Théa Vu-Bignand, VP Finance, zullen deelnemen aan de Jefferies Global Healthcare Conference, die in Londen doorgaat van 17 tot 20 november 2025. Aan de hand van QEMI, haar op fysica gebaseerde generatieve AI-platform voor de uitvinding van therapeutische moleculen, kan Aqemia...

LONDRA--(BUSINESS WIRE)--Aqemia, un'azienda all'avanguardia nel settore TechBio che integra IA generativa e fisica di ispirazione quantistica per creare nuovi farmaci, ha annunciato che Maximilien Levesque, CEO e cofondatore, e Théa Vu-Bignand, vicepresidente per le finanze, parteciperanno alla Jefferies Global Healthcare Conference, che si terrà a Londra dal 17 al 20 novembre 2025. Grazie a QEMI, la sua piattaforma di IA generativa basata sulla fisica per l'invenzione di molecole terapeutiche,...

LONDRES--(BUSINESS WIRE)--Aqemia, empresa pionera en biotecnología que combina la inteligencia artificial generativa con la física inspirada en la cuántica para inventar nuevos fármacos, acaba de anunciar que Maximilien Levesque, consejero delegado y cofundador, y Théa Vu-Bignand, vicepresidenta de Finanzas, acudirán a la Jefferies Global Healthcare Conference, que se celebrará en Londres del 17 al 20 de noviembre de 2025. Con su plataforma de IA generativa basada en la física al servicio de la...

LONDRES--(BUSINESS WIRE)--Aqemia, entreprise pionnière de la TechBio qui allie intelligence artificielle générative et physique inspirée de la mécanique quantique pour concevoir de nouveaux médicaments, annonce la participation de son PDG et cofondateur, Maximilien Levesque, ainsi que de Théa Vu-Bignand, vice-présidente des finances, à la conférence mondiale Jefferies sur la santé, qui se tiendra à Londres du 17 au 20 novembre 2025. Grâce à sa plateforme d’intelligence artificielle (IA) générat...

LONDON--(BUSINESS WIRE)--Aqemia, ein wegweisendes TechBio-Unternehmen, das generative KI und quanteninspirierte Physik zur Entwicklung von Medikamenten kombiniert, gibt bekannt, dass Maximilien Levesque, CEO und Mitbegründer, und Théa Vu-Bignand, VP Finance, an der Jefferies Global Healthcare Conference teilnehmen werden, die vom 17. bis 20. November 2025 in London stattfindet. Mit seiner physikbasierten generativen KI-Plattform für die Entwicklung therapeutischer Moleküle, QEMI, kann Aqemia au...

ROCHESTER, Minn.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The updated release reads: RION LAUNCHES RION VET TO TRANSFORM ANIMAL HEALTH WITH FIRST-IN-CLASS BIOLOGIC THERAPEUTIC; APPOINTS INDUSTRY LEADER MARK HERTHEL AS CEO; ANNOUNCES SERIES A FULFILLMENT RION, a clinical-stage regenerative medicine company and global leader in exosome-based therapeutics, today announced the formation of RION Vet, a veterinary biotechnology compa...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025...

SAN FRANCISCO--(BUSINESS WIRE)--Vagaro, the leading software for businesses in beauty, wellness, and fitness, recently announced the launch of E-Prescribe, a new integration designed to modernize and simplify how medspas and other providers manage prescriptions. Developed in partnership with ScriptSure, the feature enables practitioners to electronically send prescriptions to any retail or mail-order pharmacy within the Surescripts network. The integration eliminates the inefficiencies of faxes...

MINNEAPOLIS & ST. PAUL, Minn.--(BUSINESS WIRE)--Children’s Minnesota is thrilled to announce the Richard M. Schulze Family Foundation has committed a $5 million matching gift....

VANCOUVER, British Columbia--(BUSINESS WIRE)--Prana Labs Inc., a Vancouver-based wellness technology company and creator of the AI-powered breathwork platform Vayu, has secured $150,000 in growth funding through national innovation partners. The investment fuels Prana Labs’ mission to make mindful technology more accessible, measurable, and human-centered. Founded by Deepali Raiththa and Dhruv Adhia, Prana Labs blends neuroscience, haptic design, and AI personalization to create embodied wellne...